If you have been newly diagnosed with acute myeloid leukemia (AML) and are not eligible for intensive chemotherapy, this study may be an option for you.
We are enrolling adults ages 18 and older who have been recently diagnosed with acute myeloid leukemia. If you are interested in taking part in this study, please complete the following questionnaire.
Learn more about the PEVENAZA Study.
Step 1 of 3
By answering the following questions, you agree to have your information retained for the duration of this study, and to receiving phone or email communication related to this clinical research study.
Step 2 of 3
By submitting this questionnaire, you are agreeing to have your information retained for the duration of this study, as well as to having a study site contact you.